Bart Carruth

Bart Carruth is an accomplished sales professional with extensive experience in the pharmaceutical industry. Currently serving as Corporate Account Manager at Dendreon since January 2016, Carruth previously held the position of Sales Director at Corcept Therapeutics, leading the launch of the first approved medication for Cushing’s syndrome. Notably, Carruth managed the Western Region team at Dendreon from 2010 to 2012, earning the Region of the Year 2010 Award, and has a long tenure at Genentech, where significant achievements included overseeing national sales operations and leading the Oncology & Endocrinology Sales Division to multiple Division of the Year awards. Carruth's career began at Tokos Medical, where responsibilities included comprehensive business management in the obstetrical monitor sector. Carruth holds a BS in Business from St. University of New York, Fredonia.